Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called ...

Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called ...

AN anti-tuberculous vaccine that was given to thousands of British schoolchildren could protect against coronavirus, experts claim. The Bacillus Calmette-Guérin (BCG) jab was developed a century ago ...

The U.S. Food and Drug Administration has approved a mid-stage trial to test the efficacy of a century-old tuberculosis vaccine on reversing type 1 diabetes, according to a Reuters report. The vaccine ...

Early in the pandemic, before the advent of COVID-specific vaccines, scientists began trials to see if existing vaccines might help. One they looked at was the BCG (Bacillus Calmette-Guerin) vaccine, ...

New research in mice suggests that chronic infection with intestinal worms indirectly reduces the number of cells in lymph nodes near the skin, inhibiting the immune system's response to the Bacille ...

CAPE TOWN (Reuters) - The idea of testing the BCG vaccine in Africa against COVID-19 was bound to cause controversy, yet officials say efforts underway could, if successful, give the continent a cheap ...

A new study finds that an inexpensive vaccine used globally to prevent tuberculosis may help treat Type 1 diabetes — if given time to kick in. Six years after publishing phase 1 clinical trial results ...

(Reuters Health) - Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the ...